Accretion Nutraveda Ltd Financial Ratios
ANL · Healthcare · Current price ₹295
P/E ratio
42.1x
P/B ratio
5.8x
ROE
14.3%
ROCE
17.0%
Debt / Equity
0.12
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 42.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.12 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Accretion Nutraveda Ltd's latest numbers.
Accretion Nutraveda Ltd profitability
Accretion Nutraveda Ltd generates a return on equity of 14.3% and a return on capital employed of 17.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.12 and a P/E of 42.1x, Accretion Nutraveda Ltd is conservatively financed. Our overall business-quality score for the company is 5.7 / 10.
Understand the ratios
More on Accretion Nutraveda Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.